| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |